Resilience Care spent the week spotlighting its role in digital health and oncology telemonitoring, underscoring growing traction across Europe and the U.S. The company joined a cross-border policy panel at the French Embassy in Berlin ahead of the DMEA Connecting Digital Health conference, focusing on patient journeys in France and Germany.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The discussion, organized by Business France, highlighted the importance of telemonitoring and patient-reported outcomes to improve continuity, visibility, and personalization of care pathways. This engagement reinforces Resilience Care’s positioning within European policy and innovation circles, potentially supporting partnerships with payers, providers, and regulators.
The company also confirmed it will again exhibit at SantExpo 2026 in Paris, framing the French health system as under pressure with fragmented care pathways and underused health data. Resilience Care emphasized that its telemonitoring solutions in oncology, psychiatry, and gastroenterology are already deployed in more than 200 healthcare facilities.
These deployments suggest growing commercial reach for its remote monitoring platform as hospitals look to optimize medical time, streamline organization, and enhance data interoperability. The company’s focus on leveraging health data for both care and research aligns it with broader trends around real-world evidence and outcome-based models.
In oncology, Resilience Care highlighted the clinical and operational risks in the periods between patient visits, where it sees significant exposure for community practices. Its offering aims to deliver continuous between-visit monitoring, early warning detection, and structured clinical triage to intervene before symptoms lead to emergency visits or treatment disruptions.
Resilience Care plans to engage practice leaders at the 2026 Community Oncology Conference in Orlando, where it will be present at Booth 601. This targeted outreach signals an effort to deepen penetration in community oncology and could enhance its standing among remote patient monitoring providers focused on value-based cancer care.
Taken together, the week’s activities point to a company consolidating its position at the intersection of telemonitoring, cross-border digital health policy, and oncology care optimization, with expanding visibility across key European and U.S. markets.